This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

ARTHUR R. COLWELL, M.D.; JOSEPH H. ROHR, M.D.; BLANCHARD B. REEB, M.D.

Arch Intern Med. 1950;86(2):178-188.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

IN THE routine daily treatment of diabetes mellitus with insulin the depot insulins have become almost universally accepted as standard because of their ability to maintain smoother control of diabetes with fewer hypodermic injections. They have almost completely replaced the ordinary solutions of the hormone, "regular" or "plain" insulin and "crystalline" insulin, in the day by day maintenance therapy of diabetes. The ordinary soluble preparations of the hormone have such an intense and brief action that they are unsuitable for maintenance therapy by themselves. Their use is confined chiefly to the treatment of emergencies in diabetes in which prompt action is required, to augmentation of the slow action of depot insulins when this is desirable, to treatment of occasional patients who are allergic or unresponsive to the depot insulins and to induction of shock in psychotherapy.

How do the various depot insulins compare with one another and what are the . . . [Full Text PDF of this Article]

Author Affiliations
CHICAGO

From the Departments of Medicine, Wesley Memorial Hospital and Northwestern University Medical School.

Footnotes
This study was aided by a grant from Burroughs Wellcome & Co. (U. S. A.) Inc., Tuckahoe 7, N. Y.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?